Two patients with antiphospholipid antibody developed disseminated intravascular coagulation

Internal Medicine

Volumn 52, Issue 2, 2013, Pages 269-272

  Habe, Koji ^a   Wada, Hideo ^a   Ito Habe, Naomi ^a   Suzuki, Hikoji ^b   Nobori, Tsutomu ^a   Mizutani, Hitoshi ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Suzuka Kaisei Hospital   (Japan)

Author keywords

Antiphospholipid antibody (aPL); APS; DIC

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CEFODIZIME; DANAPAROID; FIBRIN DEGRADATION PRODUCT; GABEXATE MESILATE; HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; ULINASTATIN; WARFARIN;

ABDOMINAL PAIN; ADULT; AMYLASE BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACKACHE; CASE REPORT; CESAREAN SECTION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; LOW DRUG DOSE; PANCREATITIS; PARTIAL THROMBOPLASTIN TIME; PETECHIA; PREGNANCY; PREGNANT WOMAN; SJOEGREN SYNDROME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 84872394725     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.8308     Document Type: Article

References (10)

1. Wada H. Disseminated intravascular coagulation. Clin Chim Acta 344: 13-21, 2004.
2. Pengo V. APS--controversies in diagnosis and management, critical overview of current guidelines. Thromb Res 127: S51-S52, 2011.
3. Taylor FB Jr, Toh CH, Hoots K, Wada H, Levi M. Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327-1330, 2001.
4. Bobba RS, Johnson SR, Davis AM. A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? J Rheumatol 34: 1522-1527, 2007.
5. Willis R, Harris EN, Pierangeli SS. Pathogenesis of the Antiphospholipid Syndrome. Semin Thromb Hemost 2012 Apr 17. [Epub ahead of print].
6. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 19: 508-512, 1992.
7. Asherson RA, Espinosa G, Cervera R, et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 64: 943-946, 2005.
8. Nojima J, Masuda Y, Iwatani Y, et al. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Biochem Biophys Res Commun 365: 195-200, 2008.
9. Amengual O, Atsumi T, Koike T. Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome. Curr Vasc Pharmacol 9: 606-618, 2011.
10. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306, 2006.